Global Prostate Cancer Treatment Drugs Market Growth 2018-2023

Global Prostate Cancer Treatment Drugs Market Growth 2018-2023

Category

Pharmaceuticals

Published Date

22nd Oct 2018

Pages

135

Choose License

Final Price

Prostate cancer is the most common cancer among men, the key risk factors for prostate cancer development is being old age, genetic, obesity and race.
Over the next five years, this report projects that Prostate Cancer Treatment Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report covers the present scenario (with the base year being 2017) and the growth prospects of global Prostate Cancer Treatment Drugs market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Treatment Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, this report considers value and volume generated from the sales of the following segments:

Segmentation by product type:
Enzalutamid
Abiraterone
Leuprolide
Goserelin
Triptorelin
Histrelin
Degarelix
Sipuleucel-T
Docetaxel
Segmentation by application:
Hospital
Research Institution
Clinic
Drugstore

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
Tolmar
Astellas Pharma
AstraZeneca
Ferring Pharmaceuticals
Johnson & Johnson
Abbott
Sanofi
Ipsen
Novartis
Bayer

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Prostate Cancer Treatment Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Prostate Cancer Treatment Drugs market by identifying its various subsegments.
Focuses on the key global Prostate Cancer Treatment Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prostate Cancer Treatment Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Prostate Cancer Treatment Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents

2018-2023 Global Prostate Cancer Treatment Drugs Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Prostate Cancer Treatment Drugs Consumption 2013-2023
2.1.2 Prostate Cancer Treatment Drugs Consumption CAGR by Region
2.2 Prostate Cancer Treatment Drugs Segment by Type
2.2.1 Enzalutamid
2.2.2 Abiraterone
2.2.3 Leuprolide
2.2.4 Goserelin
2.2.5 Triptorelin
2.2.6 Histrelin
2.2.7 Degarelix
2.2.8 Sipuleucel-T
2.2.9 Docetaxel
2.2.10 Cabazitaxel
2.3 Prostate Cancer Treatment Drugs Consumption by Type
2.3.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)
2.3.2 Global Prostate Cancer Treatment Drugs Revenue and Market Share by Type (2013-2018)
2.3.3 Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)
2.4 Prostate Cancer Treatment Drugs Segment by Application
2.4.1 Hospital
2.4.2 Research Institution
2.4.3 Clinic
2.4.4 Drugstore
2.5 Prostate Cancer Treatment Drugs Consumption by Application
2.5.1 Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)
2.5.2 Global Prostate Cancer Treatment Drugs Value and Market Share by Application (2013-2018)
2.5.3 Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)

3 Global Prostate Cancer Treatment Drugs by Players
3.1 Global Prostate Cancer Treatment Drugs Sales Market Share by Players
3.1.1 Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018)
3.1.2 Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)
3.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players
3.2.1 Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018)
3.2.2 Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Prostate Cancer Treatment Drugs Sale Price by Players
3.4 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Prostate Cancer Treatment Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Prostate Cancer Treatment Drugs by Regions
4.1 Prostate Cancer Treatment Drugs by Regions
4.1.1 Global Prostate Cancer Treatment Drugs Consumption by Regions
4.1.2 Global Prostate Cancer Treatment Drugs Value by Regions
4.2 Americas Prostate Cancer Treatment Drugs Consumption Growth
4.3 APAC Prostate Cancer Treatment Drugs Consumption Growth
4.4 Europe Prostate Cancer Treatment Drugs Consumption Growth
4.5 Middle East & Africa Prostate Cancer Treatment Drugs Consumption Growth

5 Americas
5.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries
5.1.1 Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
5.1.2 Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
5.2 Americas Prostate Cancer Treatment Drugs Consumption by Type
5.3 Americas Prostate Cancer Treatment Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries
6.1.1 APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
6.1.2 APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
6.2 APAC Prostate Cancer Treatment Drugs Consumption by Type
6.3 APAC Prostate Cancer Treatment Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Prostate Cancer Treatment Drugs by Countries
7.1.1 Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
7.1.2 Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
7.2 Europe Prostate Cancer Treatment Drugs Consumption by Type
7.3 Europe Prostate Cancer Treatment Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Prostate Cancer Treatment Drugs by Countries
8.1.1 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type
8.3 Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Prostate Cancer Treatment Drugs Distributors
10.3 Prostate Cancer Treatment Drugs Customer

11 Global Prostate Cancer Treatment Drugs Market Forecast
11.1 Global Prostate Cancer Treatment Drugs Consumption Forecast (2018-2023)
11.2 Global Prostate Cancer Treatment Drugs Forecast by Regions
11.2.1 Global Prostate Cancer Treatment Drugs Forecast by Regions (2018-2023)
11.2.2 Global Prostate Cancer Treatment Drugs Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Prostate Cancer Treatment Drugs Forecast by Type
11.8 Global Prostate Cancer Treatment Drugs Forecast by Application

12 Key Players Analysis
12.1 Tolmar
12.1.1 Company Details
12.1.2 Prostate Cancer Treatment Drugs Product Offered
12.1.3 Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Tolmar News
12.2 Astellas Pharma
12.2.1 Company Details
12.2.2 Prostate Cancer Treatment Drugs Product Offered
12.2.3 Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 Astellas Pharma News
12.3 AstraZeneca
12.3.1 Company Details
12.3.2 Prostate Cancer Treatment Drugs Product Offered
12.3.3 AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 AstraZeneca News
12.4 Ferring Pharmaceuticals
12.4.1 Company Details
12.4.2 Prostate Cancer Treatment Drugs Product Offered
12.4.3 Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Ferring Pharmaceuticals News
12.5 Johnson & Johnson
12.5.1 Company Details
12.5.2 Prostate Cancer Treatment Drugs Product Offered
12.5.3 Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Johnson & Johnson News
12.6 Abbott
12.6.1 Company Details
12.6.2 Prostate Cancer Treatment Drugs Product Offered
12.6.3 Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Abbott News
12.7 Sanofi
12.7.1 Company Details
12.7.2 Prostate Cancer Treatment Drugs Product Offered
12.7.3 Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Sanofi News
12.8 Ipsen
12.8.1 Company Details
12.8.2 Prostate Cancer Treatment Drugs Product Offered
12.8.3 Ipsen Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Ipsen News
12.9 Novartis
12.9.1 Company Details
12.9.2 Prostate Cancer Treatment Drugs Product Offered
12.9.3 Novartis Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Novartis News
12.10 Bayer
12.10.1 Company Details
12.10.2 Prostate Cancer Treatment Drugs Product Offered
12.10.3 Bayer Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
12.10.4 Main Business Overview
12.10.5 Bayer News

13 Research Findings and Conclusion
List of Tables and Figures_x000D_
_x000D_
Figure Picture of Prostate Cancer Treatment Drugs_x000D_
Table Product Specifications of Prostate Cancer Treatment Drugs_x000D_
Figure Prostate Cancer Treatment Drugs Report Years Considered_x000D_
Figure Market Research Methodology_x000D_
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate 2013-2023 (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate 2013-2023 ($ Millions)_x000D_
Table Prostate Cancer Treatment Drugs Consumption CAGR by Region 2013-2023 ($ Millions)_x000D_
Figure Product Picture of Enzalutamid_x000D_
Table Major Players of Enzalutamid_x000D_
Figure Product Picture of Abiraterone_x000D_
Table Major Players of Abiraterone_x000D_
Figure Product Picture of Leuprolide_x000D_
Table Major Players of Leuprolide_x000D_
Figure Product Picture of Goserelin_x000D_
Table Major Players of Goserelin_x000D_
Figure Product Picture of Triptorelin_x000D_
Table Major Players of Triptorelin_x000D_
Figure Product Picture of Histrelin_x000D_
Table Major Players of Histrelin_x000D_
Figure Product Picture of Degarelix_x000D_
Table Major Players of Degarelix_x000D_
Figure Product Picture of Sipuleucel-T_x000D_
Table Major Players of Sipuleucel-T_x000D_
Figure Product Picture of Docetaxel_x000D_
Table Major Players of Docetaxel_x000D_
Figure Product Picture of Cabazitaxel_x000D_
Table Major Players of Cabazitaxel_x000D_
Table Global Consumption Sales by Type (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Revenue by Type (2013-2018) ($ million)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018) ($ Millions)_x000D_
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Type (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Sale Price by Type (2013-2018)_x000D_
Figure Prostate Cancer Treatment Drugs Consumed in Hospital_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Hospital (2013-2018) ($ Millions)_x000D_
Figure Global Hospital YoY Growth ($ Millions)_x000D_
Figure Prostate Cancer Treatment Drugs Consumed in Research Institution_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Research Institution (2013-2018) ($ Millions)_x000D_
Figure Global Research Institution YoY Growth ($ Millions)_x000D_
Figure Prostate Cancer Treatment Drugs Consumed in Clinic_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Clinic (2013-2018) ($ Millions)_x000D_
Figure Global Clinic YoY Growth ($ Millions)_x000D_
Figure Prostate Cancer Treatment Drugs Consumed in Drugstore_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Market: Drugstore (2013-2018) ($ Millions)_x000D_
Figure Global Drugstore YoY Growth ($ Millions)_x000D_
Table Global Consumption Sales by Application (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Value by Application (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Application (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Sale Price by Application (2013-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Sales by Players (2016-2018) (MT)_x000D_
Table Global Prostate Cancer Treatment Drugs Sales Market Share by Players (2016-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2016_x000D_
Figure Global Prostate Cancer Treatment Drugs Sales Market Share by Players in 2017_x000D_
Table Global Prostate Cancer Treatment Drugs Revenue by Players (2016-2018) ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Revenue Market Share by Players (2016-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2016_x000D_
Figure Global Prostate Cancer Treatment Drugs Revenue Market Share by Players in 2017_x000D_
Table Global Prostate Cancer Treatment Drugs Sale Price by Players (2016-2018)_x000D_
Figure Global Prostate Cancer Treatment Drugs Sale Price by Players in 2017_x000D_
Table Global Prostate Cancer Treatment Drugs Manufacturing Base Distribution and Sales Area by Players_x000D_
Table Players Prostate Cancer Treatment Drugs Products Offered_x000D_
Table Prostate Cancer Treatment Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption by Regions 2013-2018 (MT)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018_x000D_
Figure Global Prostate Cancer Treatment Drugs Consumption Market Share by Regions 2013-2018_x000D_
Table Global Prostate Cancer Treatment Drugs Value by Regions 2013-2018 ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018_x000D_
Figure Global Prostate Cancer Treatment Drugs Value Market Share by Regions 2013-2018_x000D_
Figure Americas Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2013-2018 (MT)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2013-2018 ($ Millions)_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017_x000D_
Table Americas Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Americas Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)_x000D_
Table Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017_x000D_
Figure United States Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure United States Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Canada Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Canada Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Mexico Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Mexico Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017_x000D_
Table APAC Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table APAC Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)_x000D_
Table APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017_x000D_
Figure China Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure China Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Japan Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Japan Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Korea Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Korea Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Southeast Asia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure India Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure India Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Australia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Australia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017_x000D_
Table Europe Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Europe Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)_x000D_
Table Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017_x000D_
Figure Germany Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Germany Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure France Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure France Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure UK Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure UK Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Italy Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Italy Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Russia Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Russia Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Spain Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Spain Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Countries (2013-2018) (MT)_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Countries in 2017_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Value by Countries (2013-2018) ($ Millions)_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries (2013-2018)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value Market Share by Countries in 2017_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Type (2013-2018) (MT)_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type (2013-2018)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Type in 2017_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption by Application (2013-2018) (MT)_x000D_
Table Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application (2013-2018)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption Market Share by Application in 2017_x000D_
Figure Egypt Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Egypt Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure South Africa Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure South Africa Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Israel Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Israel Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure Turkey Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure Turkey Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption Growth 2013-2018 (MT)_x000D_
Figure GCC Countries Prostate Cancer Treatment Drugs Value Growth 2013-2018 ($ Millions)_x000D_
Table Prostate Cancer Treatment Drugs Distributors List_x000D_
Table Prostate Cancer Treatment Drugs Customer List_x000D_
Figure Global Prostate Cancer Treatment Drugs Consumption Growth Rate Forecast (2018-2023) (MT)_x000D_
Figure Global Prostate Cancer Treatment Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Countries (2018-2023) (MT)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Forecast by Regions_x000D_
Table Global Prostate Cancer Treatment Drugs Value Forecast by Countries (2018-2023) ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Regions_x000D_
Figure Americas Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Americas Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure APAC Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Europe Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Middle East & Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure United States Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure United States Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Canada Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Canada Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Mexico Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Mexico Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Brazil Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Brazil Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure China Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure China Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Japan Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Japan Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Korea Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Korea Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Southeast Asia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Southeast Asia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure India Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure India Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Australia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Australia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Germany Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Germany Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure France Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure France Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure UK Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure UK Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Italy Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Italy Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Russia Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Russia Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Spain Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Spain Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Egypt Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Egypt Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure South Africa Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure South Africa Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Israel Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Israel Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure Turkey Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure Turkey Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Figure GCC Countries Prostate Cancer Treatment Drugs Consumption 2018-2023 (MT)_x000D_
Figure GCC Countries Prostate Cancer Treatment Drugs Value 2018-2023 ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Type (2018-2023) (MT)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Type (2018-2023)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Forecast by Type (2018-2023) ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Type (2018-2023)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Forecast by Application (2018-2023) (MT)_x000D_
Table Global Prostate Cancer Treatment Drugs Consumption Market Share Forecast by Application (2018-2023)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Forecast by Application (2018-2023) ($ Millions)_x000D_
Table Global Prostate Cancer Treatment Drugs Value Market Share Forecast by Application (2018-2023)_x000D_
Table Tolmar Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Tolmar Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Tolmar Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Astellas Pharma Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Astellas Pharma Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table AstraZeneca Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure AstraZeneca Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Ferring Pharmaceuticals Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Johnson & Johnson Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Johnson & Johnson Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Abbott Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Abbott Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Sanofi Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Sanofi Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Ipsen Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Ipsen Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Ipsen Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Novartis Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Novartis Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_
Table Bayer Basic Information, Manufacturing Base, Sales Area and Its Competitors_x000D_
Table Bayer Prostate Cancer Treatment Drugs Sales, Revenue, Price and Gross Margin (2016-2018)_x000D_
Figure Bayer Prostate Cancer Treatment Drugs Market Share (2016-2018)_x000D_

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us